Ion Channel Screening
Whether you want to explore an ion channel as a potential new target or understand cardiovascular, CNS and other liabilities, ApconiX can help you with our electrophysiology expertise, customer-focused flexibility and rapid delivery of high data quality. The services we offer include hERG screening and CiPA assays, a CNS panel of 15 ion channels and a MicroElectrode Array assay using human derived neuronal stem cells. These are complemented by a wide range of assay development and ion channel screening services.
Make safety part of drug design with early drug discovery screening.
Rapid high quality ion channel screening
for hERG and the CiPA paradigm
An integrated in vitro screening approach for seizure liability to support hazard identification and decision making in early drug discovery
Including assay development, manual patch clamp, sustainability and investigative research.
Transform ion channel IC50
values into mechanistic pro-arrhythmia risk
assessments to inform clinical development.
Directors and co-founders Dr Michael Morton
and Dr Richard Knight are joined by
members of the laboratory team
Dr Kimberly Rockley and Hannah Jennings.